Welcome to MEKEI

The mission of the MEKEI research institute is to use research and education to help transform the countries of the Middle East and North Africa to advanced, knowledge-based societies led by sustainable innovation and social advance.

Evently

Stay Connected & Follow us

Simply enter your keyword and we will help you find what you need.

What are you looking for?

(pp.155-179) S. N. A. El-Rahman and S. S. Jameel ‘Efficacy of nano curcumin in F2-isoprostanes in male rats treated with Cisplatin and Methotrexate as chemotherapy drugs’, IJSR, Vol. 4, No. 2, 2014

(pp.155-179) S. N. A. El-Rahman and S. S. Jameel ‘Efficacy of nano curcumin in F2-isoprostanes in male rats treated with Cisplatin and Methotrexate as chemotherapy drugs’, IJSR, Vol. 4, No. 2, 2014

IJSRSoheir N. Abd El-Rahman, Agriculture Research Center, Egypt
Suhailah S. Al-Jameel, University of Dammam, Saudi Arabia

Purpose: This work is based on nanoparticipation technique for preparation of curcumin nanoparticles (CURNPs) and study the effect of CURNPs (60, 30 mg/kg b.w) as antioxidants on the nephrotoxicity induced by cisplatin (CDDP) (6 mg/kg b.w i.p) and methotrexate (MTX) (20 mg/kg b.w i.p).
Design/methodology/approach: Physicochemical characterization of CURNPs was studied by Zetasizer Nano ZS, TEM and BET surface area. Urea, creatinine, SOD, CAT and F2-Isoprostanes (F2-isoPs) in serum were estimated. Also, morphological changes of kidney were studied.
Findings: The results indicated that the CDDP and MTX induced increase of urea, creatinine and F2-IsoPs concentrations and decline of serum antioxidant enzymes (SOD and CAT) activities. On the other hand, urea, creatinine and F2-IsoPs, were reduced and (SOD and CAT) activities were increased significantly (p<0.05) in the CURNPs (60, 30 mg/kg b.w) + CDDP/ MTX treated groups. Moreover, CURNPs (60, 30 mg/kg b.w) + CDDP/ MTX treated groups resulted in a marked of morphological protection against the drugs induced nephrotoxicity and confirmed the pathological improvement in the kidney tissue.
Originality/value: This study concluded that CURNPs has a strong potential to be used as a strong antioxidant in CDDP and MTX nephrotoxicity. Most importantly, CURNPs (60 mg/kg b.w) was much more effective and better nephroprotective agent than CURNPs (30 mg/kg b.w). These findings provide further understanding for the possible therapeutic effects of CURNPs in further pre-clinical and clinical research.
Keywords: Curcumin nanoparticles (CURNPs); F2-isoprostans (F2-isoPs); Cisplatin (CDDP); Methotrexate (MTX);  Nephrotoxicity

IJSR_VNABD EL-RAHMAN_AL-JAMEEL-Itemid=.pdf
IJSR_VNABD EL-RAHMAN_AL-JAMEEL-Itemid=.pdf